Oscar Health (NYSE:OSCR) Cut to “Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Oscar Health (NYSE:OSCR) from a hold rating to a sell rating in a research report released on Saturday morning.

OSCR has been the topic of several other reports. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. The Goldman Sachs Group began coverage on Oscar Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price target for the company. Barclays upped their price objective on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a report on Monday, November 10th. Finally, Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $13.00 to $25.00 in a research report on Tuesday, November 25th. One equities research analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Reduce” and a consensus target price of $14.86.

Oscar Health Stock Down 0.1%

OSCR opened at $16.75 on Friday. The stock’s fifty day simple moving average is $17.98 and its 200 day simple moving average is $16.97. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.80. The stock has a market cap of $4.43 billion, a PE ratio of -14.95 and a beta of 1.88. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period in the previous year, the company earned ($0.22) earnings per share. As a group, research analysts expect that Oscar Health will post 0.69 earnings per share for the current year.

Insider Transactions at Oscar Health

In related news, insider Janet Liang sold 7,338 shares of the firm’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the transaction, the insider owned 172,527 shares in the company, valued at $2,862,222.93. This trade represents a 4.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mario Schlosser sold 395,000 shares of the business’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the sale, the insider directly owned 501,148 shares in the company, valued at $9,236,157.64. The trade was a 44.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 739,472 shares of company stock worth $12,616,880. 25.11% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Thrive Capital Management LLC grew its position in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Wealthspire Advisors LLC bought a new stake in Oscar Health in the first quarter valued at approximately $137,000. Vanguard Group Inc. increased its position in Oscar Health by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock valued at $258,247,000 after purchasing an additional 700,469 shares during the period. Swiss National Bank raised its holdings in Oscar Health by 1.0% during the 1st quarter. Swiss National Bank now owns 328,200 shares of the company’s stock worth $4,303,000 after purchasing an additional 3,400 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in shares of Oscar Health by 19.0% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company’s stock worth $6,581,000 after purchasing an additional 79,979 shares during the period. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.